Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Diindolylmethane (DIM)

Diindolylmethane (DIM) · also known as DIM, Cruciferous vegetable extract

DIM can shift the ratio of estrogen metabolites in urine. In a human randomized trial, the 2/16α-hydroxyestrone ratio rose. The clinical meaning of this ratio change is unclear. It is also uncertain whether it reflects induction of a specific enzyme pathway or any health benefit.

Typical dose: Bioenhanced DIM at 100–200 mg/day, taken with a meal.
Absorption and forms: Pure DIM is poorly soluble in water, and oral exposure is usually low. Bioenhanced combination products may improve exposure. One example is BioResponse DIM, which is microencapsulated with vitamin E, phospholipids and polyethylene glycol. These products are not interchangeable, though, and it is not accurate to say that every ordinary product has very low absorption.

Mechanisms of action

Estrogen metabolism shunting and detoxification pathway tuning

★★★☆☆Mechanism evidence: grade APrimary target

DIM can raise the urinary ratio of 2-hydroxyestrone to 16α-hydroxyestrone. This change in the metabolite ratio cannot on its own prove a specific enzyme pathway, a lower cancer risk or a clinical detox benefit. Its meaning is still unclear.

References (2)
  1. Thomson et al. 2017 · Human randomized placebo-controlled trial: DIM raised the urinary 2/16α-hydroxyestrone ratio
  2. Overall assessment · Evidence limits: the metabolite ratio change in this trial cannot show specific CYP1A1 induction, a lower cancer risk or clinical “detoxification”

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade CSecondary target

In cell and mouse experiments, DIM can inhibit NF-κB activation and reduce brain inflammation. Related pathway changes were also seen in animal lung tissue. No reliable trial has directly shown whether NF-κB activity changes in humans after standard oral DIM.

References (2)
  1. Kim et al. 2014 · Cell and mouse experiments: DIM inhibited NF-κB activation in cells and reduced brain inflammation in mice
  2. 2022 · Animal experiment: DIM was associated with changes in NF-κB-related pathways in lung tissue

Safety and drug interactions

People with low estradiol should not take high doses. Women who are trying to conceive, and those who are pregnant or breastfeeding, should use DIM only under a doctor’s guidance. People taking tamoxifen should be careful: in one randomized trial, DIM lowered the level of some active tamoxifen metabolites. The clinical consequence is uncertain, so ask a doctor first.

With Tamoxifen / aromatase inhibitors Needs attention

Tamoxifen, letrozole, anastrozole

DIM may lower levels of active tamoxifen metabolites. Consult an oncologist first if you are being treated for breast cancer.

Open in the interactive app ›